|
1
|
Beele H, Smet S, Van Damme N and Beeckman
D: Incontinence-associated dermatitis: Pathogenesis, contributing
factors, prevention and management options. Drugs Aging. 35:1–10.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Koudounas S, Bader DL and Voegeli D:
Knowledge gaps in the etiology and pathophysiology of
incontinence-associated dermatitis: A scoping review. J Wound
Ostomy Continence Nurs. 47:388–395. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Raepsaet C, Fourie A, Van Hecke A,
Verhaeghe S and Beeckman D: Management of incontinence-associated
dermatitis: A systematic review of monetary data. Int Wound J.
18:79–94. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang Y, Leng M, Guo J, Duan J and Wang Z:
The effectiveness of faecal collection devices in preventing
incontinence-associated dermatitis in critically ill patients with
faecal incontinence: A systematic review and meta-analysis. Aust
Crit Care. 34:103–112. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lichterfeld-Kottner A, El Genedy M,
Lahmann N, Blume-Peytavi U, Büscher A and Kottner J: Maintaining
skin integrity in the aged: A systematic review. Int J Nurs Stud.
103(103509)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Barakat-Johnson M, Basjarahil S, Campbell
J, Cunich M, Disher G, Geering S, Ko N, Lai M, Leahy C, Leong T, et
al: Implementing best available evidence into practice for
incontinence-associated dermatitis in Australia: A multisite
multimethod study protocol. J Tissue Viability. 30:67–77.
2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gates BP, Vess J, Long MA and Johnson E:
Decreasing incontinence-associated dermatitis in the surgical
intensive care unit: A quality improvement project. J Wound Ostomy
Continence Nurs. 46:327–331. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kottner J, Hahnel E, El Genedy M, Neumann
K and Balzer K: Enhancing SKIN health and safety in aged CARE
(SKINCARE Trial): A study protocol for an exploratory
cluster-randomized pragmatic trial. Trials. 20(302)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Phipps L, Gray M and Call E: Time of onset
to changes in skin condition during exposure to synthetic urine: A
prospective study. J Wound Ostomy Continence Nurs. 46:315–320.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Acton C, Ivins N, Bainbridge P and
Browning P: Management of incontinence-associated dermatitis
patients using a skin protectant in acute care: A case series. J
Wound Care. 29:18–26. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Van Damme N, Van Hecke A, Himpens A,
Verhaeghe S and Beeckman D: Design and psychometric testing of the
attitude towards the prevention of incontinence-associated
dermatitis instrument (APrIAD). Int Wound J. 16:492–502.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gray M: Context for practice: Prevention
of pressure injury and incontinence-associated dermatitis. J Wound
Ostomy Continence Nurs. 44:406–408. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kayser SA, Phipps L, VanGilder CA and
Lachenbruch C: Examining prevalence and risk factors of
incontinence-associated dermatitis using the international pressure
ulcer prevalence survey. J Wound Ostomy Continence Nurs.
46:285–290. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Borchert K, Bliss DZ, Savik K and
Radosevich DM: The incontinence-associated dermatitis and its
severity instrument: Development and validation. J Wound Ostomy
Continence Nurs. 37:527–535. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Arnold-Long M and Johnson E: Epidemiology
of incontinence-associated dermatitis and intertriginous dermatitis
(Intertrigo) in an acute care facility. J Wound Ostomy Continence
Nurs. 46:201–206. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Minematsu T, Yamamoto Y, Nagase T, Naito
A, Takehara K, Iizaka S, Komagata K, Huang L, Nakagami G, Akase T,
et al: Aging enhances maceration-induced ultrastructural alteration
of the epidermis and impairment of skin barrier function. J
Dermatol Sci. 62:160–168. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Been RA, Bernatchez SF, Conrad-Vlasak DM,
Asmus RA, Ekholm BP and Parks PJ: In vivo methods to evaluate a new
skin protectant for loss of skin integrity. Wound Repair Regen.
24:851–859. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mugita Y, Minematsu T, Huang L, Nakagami
G, Kishi C, Ichikawa Y, Nagase T, Oe M, Noguchi H, Mori T, et al:
Histopathology of incontinence-associated skin lesions: Inner
tissue damage due to invasion of proteolytic enzymes and bacteria
in macerated rat skin. PLoS One. 10(e0138117)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wen Z, Zhu W, Liu Q, Zhang H, Mei B and
Shen M: Development of an animal model for inducing various degrees
of severity of incontinence-associated dermatitis. J Wound Ostomy
Continence Nurs. 44:578–582. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Biçer Ş, Sayar İ, Gürsul C, Işık A, Aydın
M, Peker K and Demiryilmaz İ: Use of ozone to treat ileostomy
dermatitis in an experimental rat model. Med Sci Monit. 22:757–765.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hoedl M and Eglseer D: Which
characteristics of fecal incontinence predispose
incontinence-associated dermatitis? A classification and regression
tree analysis. Adv Skin Wound Care. 34:103–108. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Koudounas S, Mugita Y, Minematsu T,
Nakagami G, Weller C and Sanada H: Does the presence of bacterial
urinary infection contribute to the development of
incontinence-associated dermatitis? A scoping review. J Tissue
Viability. 30:256–261. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hödl M, Blanař V, Amir Y and Lohrmann C:
Association between incontinence, incontinence-associated
dermatitis and pressure injuries: A multisite study among
hospitalised patients 65 years or older. Australas J Dermatol.
61:e144–e146. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Coyer F, Campbell J and Doubrovsky A:
Efficacy of incontinence-associated dermatitis intervention for
patients in intensive care: An open-label pilot randomized
controlled trial. Adv Skin Wound Care. 33:375–382. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tay C, Yuh AS, Sheau Lan EL, Ong CE,
Aloweni F and Lopez V: Development and validation of the
incontinence associated dermatitis knowledge, attitude and practice
questionnaire. J Tissue Viability. 29:244–251. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Werth SL and Justice R: Prevalence of
moisture-associated skin damage in an acute care setting: Outcomes
from a quality improvement project. J Wound Ostomy Continence Nurs.
46:51–54. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Park KH: The effect of a silicone border
foam dressing for prevention of pressure ulcers and
incontinence-associated dermatitis in intensive care unit patients.
J Wound Ostomy Continence Nurs. 41:424–429. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Aquino M and Rosner G: Systemic contact
dermatitis. Clin Rev Allergy Immunol. 56:9–18. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kolesnik M, Franke I, Lux A, Quist SR and
Gollnick HP: Eczema in psoriatico: An important differential
diagnosis between chronic allergic contact dermatitis and psoriasis
in palmoplantar localization. Acta Derm Venereol. 98:50–58.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gil TY, Kang YM, Eom YJ, Hong CH and An
HJ: Anti-atopic dermatitis effect of seaweed fulvescens extract via
inhibiting the STAT1 pathway. Mediators Inflamm.
2019(3760934)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yang BY, Cheng YG, Liu Y, Liu Y, Tan JY,
Guan W, Guo S and Kuang HX: Datura Metel L. Ameliorates
imiquimod-induced psoriasis-like dermatitis and inhibits
inflammatory cytokines production through TLR7/8-MyD88-NF-κB-NLRP3
Inflammasome pathway. Molecules. 24(2157)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Irrera N, Vaccaro M, Bitto A, Pallio G,
Pizzino G, Lentini M, Arcoraci V, Minutoli L, Scuruchi M, Cutroneo
G, et al: BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome
pathways and protects against IMQ-induced psoriasis. Clin Sci
(Lond). 131:487–498. 2017.PubMed/NCBI View Article : Google Scholar
|
